Wednesday, April 17, 2019 11:04:59 AM
52 week low is $6.80. IMUX has had a 30 million dollar cash infusion and merged with stronger companies. IMUX looks to be entering buy territory real soon at the rate it is falling. IMO
Recent IMUX News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:05:25 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 04/09/2026 08:30:55 PM
- Immunic to Participate in Scientific and Medical Conferences in April • PR Newswire (US) • 04/09/2026 10:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/02/2026 08:31:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 11:00:32 AM
- Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement • PR Newswire (US) • 04/01/2026 10:30:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:01:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 10:45:34 AM
- Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton • PR Newswire (US) • 03/31/2026 10:30:00 AM
- Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium • PR Newswire (US) • 03/10/2026 10:30:00 AM
- Immunic to Participate in Investor Conferences in March • PR Newswire (US) • 03/03/2026 11:30:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/02/2026 09:30:18 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 12:16:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 12:00:56 PM
- Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update • PR Newswire (US) • 02/26/2026 11:30:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/24/2026 09:38:34 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/24/2026 09:15:14 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/20/2026 10:00:26 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/20/2026 09:43:57 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/19/2026 09:30:01 PM
